Combination of bioaffinity ultrafiltration-UFLC-ESI-Q/TOF-MS/MS, in silico docking and multiple complex networks to explore antitumor mechanism of topoisomerase I inhibitors from Artemisiae Scopariae Herba
-
Published:2023-09-12
Issue:1
Volume:23
Page:
-
ISSN:2662-7671
-
Container-title:BMC Complementary Medicine and Therapies
-
language:en
-
Short-container-title:BMC Complement Med Ther
Author:
Chen Tong,Hu Jingbo,Wang Huan,Tan Nana,Qi Jianzhao,Wang Xiaoling,Wang Le
Abstract
Abstract
Background
Artemisiae Scopariae Herba (ASH) has been widely used as plant medicine in East Asia with remarkable antitumor activity. However, the underlying mechanisms have not been fully elucidated.
Methods
This study aimed to construct a multi-disciplinary approach to screen topoisomerase I (topo I) inhibitors from ASH extract, and explore the antitumor mechanisms. Bioaffinity ultrafiltration-UFLC-ESI-Q/TOF-MS/MS was used to identify chemical constitution of ASH extract as well as the topo I inhibitors, and in silico docking coupled with multiple complex networks was applied to interpret the molecular mechanisms.
Results
Crude ASH extract exhibited toxicogenetic and antiproliferative activities on A549 cells. A series of 34 ingredients were identified from the extract, and 6 compounds were screened as potential topo I inhibitors. Docking results showed that the formation of hydrogen bond and π-π stacking contributed most to their binding with topo I. Interrelationships among the 6 compounds, related targets and pathways were analyzed by multiple complex networks model. These networks displayed power-law degree distribution and small-world property. Statistical analysis indicated that isorhamnetin and quercetin were main active ingredients, and that chemical carcinogenesis-reactive oxygen species was the critical pathway. Electrophoretic results showed a therapeutic effect of ASH extract on the conversion of supercoiled DNA to relaxed forms, as well as potential synergistic effect of isorhamnetin and quercetin.
Conclusions
The results improved current understanding of Artemisiae Scopariae Herba on the treatment of tumor. Moreover, the combination of multi-disciplinary methods provided a new strategy for the study of bioactive constituents in medicinal plants.
Funder
Shaanxi Education Commission
Innovation Capability Support Program of Shaanxi
National Natural Science Foundation of China
Shaanxi Science and Technology Commission
Publisher
Springer Science and Business Media LLC
Subject
Complementary and alternative medicine
Reference53 articles.
1. Cai Y, Zheng Q, Sun R, Wu J, Li X, Liu R. Recent progress in the study of Artemisiae Scopariae Herba (Yin Chen), a promising medicinal herb for liver diseases. Biomed Pharmacother. 2020;130: 110513.
2. Geng C-A, Huang X-Y, Chen X-L, Ma Y-B, Rong G-Q, Zhao Y, Zhang X-M, Chen J-J. Three new anti-HBV active constituents from the traditional chinese herb of Yin-Chen (Artemisia scoparia). J Ethnopharmacol. 2015;176:109–17.
3. Nigam M, Atanassova M, Mishra AP, Pezzani R, Devkota HP, Plygun S, Salehi B, Setzer WN, Sharifi-Rad J. Bioactive compounds and health benefits of Artemisia species. Nat Prod Commun. 2019;14(7):1934578X19850354.
4. Ding J, Wang L, He C, Zhao J, Si L, Huang H. Artemisia scoparia: traditional uses, active constituents and pharmacological effects. J Ethnopharmacol. 2021;273: 113960.
5. LIU Y-P. Research progress on pharmacological effect of Artemisiae Scopariae Herba. Chin Traditional Herb Drugs. 2019;50(9):2235–41.